Prentiss Smith & Co’s Ultralife ULBI Stock Holding History

Prentiss Smith & Co’s Portfolio ULBI Stock Details ULBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-700	Closed	-$5K	–	253
2017 Q2	$5K	Hold	700	–	–	﹤0.01%	224
2017 Q1	$4K	Hold	700	–	–	﹤0.01%	220
2016 Q4	$3K	Hold	700	–	–	﹤0.01%	238
2016 Q3	$3K	Hold	700	–	–	﹤0.01%	232
2016 Q2	$4K	Hold	700	–	–	﹤0.01%	240
2016 Q1	$4K	Hold	700	–	–	﹤0.01%	276
2015 Q4	$5K	Hold	700	–	–	﹤0.01%	279
2015 Q3	$4K	Hold	700	–	–	﹤0.01%	274
2015 Q2	$3K	Hold	700	–	–	﹤0.01%	269
2015 Q1	$3K	Hold	700	–	–	﹤0.01%	289
2014 Q4	$2K	Hold	700	–	–	﹤0.01%	303
2014 Q3	$2K	Hold	700	–	–	﹤0.01%	229
2014 Q2	$3K	Hold	700	–	–	﹤0.01%	223
2014 Q1	$3K	Hold	700	–	–	﹤0.01%	234
2013 Q4	$2K	Hold	700	–	–	﹤0.01%	237
2013 Q3	$3K	Hold	700	–	–	﹤0.01%	221
2013 Q2	$2K	Buy	+700	New	+$2.73K	﹤0.01%	246

Other funds holding ULBI

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GXMC

Global X Management Company New York $5.62B AUM 10.7% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

Algert Global San Francisco, California $8.43B AUM 80.94% 1-Year Est. Return

Prentiss Smith & Co's ULBI Position: Q3 2017 in Review

Prentiss Smith & Co sold out of Ultralife (ULBI) in Q3 2017, closing a stake of 700 shares — an estimated $5K sold.

Prentiss Smith & Co first reported a position in ULBI in Q2 2013 and held it in 17 quarters. The position peaked at $5K in Q2 2017. 38 funds tracked by Wall St. Rank hold ULBI as of Q3 2017.

Prentiss Smith & Co reported no remaining Ultralife position as of Q3 2017 after selling out during the quarter.
Prentiss Smith & Co sold 700 Ultralife shares in Q3 2017, an estimated $5K.
Prentiss Smith & Co first reported a position in Ultralife in Q2 2013 and held it in 17 quarters.
Prentiss Smith & Co's Ultralife position peaked at $5K in Q2 2017.
38 funds tracked by Wall St. Rank held Ultralife as of Q3 2017.

Based on Prentiss Smith & Co's 13F filing for Q3 2017, filed 23 Oct 2017.